Ahead of CPHI Frankfurt (November 1-3, 2022), a new CPHI Report predicts a significant shift is under way in global outsourcing strategies, with innovators now mapping a product’s full life-cycle development as early as pre-clinical.   A key finding is that innovators across the industry are planning ‘pharma-ready’ synthetic routes much earlier in the development process, with ‘phase appropriate development’ increasingly seen as outdated – and particularly inappropriate for accelerated pathway...